Clinical Features of Autonomic Dysfunction in Children with Anti-N-methyl-D Aspartic Receptor Encephalitis

Overview

Journal Ital J Pediatr

Publisher Biomed Central

Date 2025 Jan 18

PMID 39827163

Authors

Dongqing Li

Jing Sun

Guannan Li

Shuo Miao

Jian Yang

Jianzhao Zhang

Affiliations

Soon will be listed here.

Abstract

Background: Anti-N-methyl-D-aspartic receptor encephalitis (Anti-NMDAR encephalitis) is the most prevalent form of autoimmune encephalitis in pediatric patients. Autonomic dysfunction is a frequent symptom of Anti-NMDAR encephalitis, yet it often goes unnoticed by pediatricians. Studies have indicated that pediatric patients with autonomic dysfunction exhibit a poorer prognosis compared to those without. To date, research on autonomic dysfunction in encephalitis has predominantly focused on adults, with no studies conducted on pediatric populations. This analysis examines the clinical features of pediatric patients with Anti-NMDAR encephalitis complicated by autonomic dysfunction.

Methods: We performed a retrospective analysis of patients diagnosed with Anti-NMDAR encephalitis at the Department of Neurology, Children's Hospital affiliated to the Capital Institute of Pediatrics, from June 2017 to June 2023. Patients were categorized based on the presence or absence of autonomic dysfunction during their illness. We summarized and compared the clinical features of children with autonomic dysfunction and analyzed the risk factors for its development in pediatric Anti-NMDAR encephalitis patients.

Results: A total of 56 children were included in this study. Twenty-two (39.3%) exhibited autonomic nervous dysfunction. The most prevalent symptom of autonomic dysfunction was cardiovascular autonomic dysfunction(21/22, 95%),with the specific manifestations being sinus tachycardia (8 cases), ventricular premature beats (2 cases), atrioventricular block (2 cases), atrial premature beats (3 cases), and sinus bradycardia (4 cases),hypertension(1 case) and cardiac arrest(1 case). Other symptoms included gland secretion dysfunction (19/22, 86%),ventilate dysfunction(3/22,14%), thermoregulatory dysfunction (3/22,14%), bladder dysfunction(2/22,9%). Compared to the group without autonomic dysfunction, the group with dysfunction showed significantly higher rates of prodrome infection, tumor complications (all ovarian teratoma), consciousness disturbance, elevated cerebrospinal fluid protein, initiation of second-line and long-term immunotherapy, length of hospital stay, and hospitalization costs (P < 0.05).

Conclusion: Among pediatric patients with Anti-NMDAR encephalitis, cardiovascular autonomic dysfunction is the most common form of autonomic dysfunction. Those with autonomic dysfunction have a worse prognosis and longer hospital stays. Active initiation of second-line and long-term immunotherapy is recommended.

References

Yamakawa M, Mukaino A, Kimura A, Nagasako Y, Kitazaki Y, Maeda Y . Antibodies to the α3 subunit of the ganglionic-type nicotinic acetylcholine receptors in patients with autoimmune encephalitis. J Neuroimmunol. 2020; 349:577399. DOI: 10.1016/j.jneuroim.2020.577399. View

Lee M, Lawn N, Prentice D, Chan J . Anti-NMDA receptor encephalitis associated with ictal asystole. J Clin Neurosci. 2011; 18(12):1716-8. DOI: 10.1016/j.jocn.2011.03.024. View

Hu C, Pan X, Zhang M, Chen H . Paroxysmal speech disorder as the initial symptom in a young adult with anti-N-methyl-D-aspartate receptor encephalitis: A case report. World J Clin Cases. 2022; 10(24):8648-8655. PMC: 9453376. DOI: 10.12998/wjcc.v10.i24.8648. View

Liu B, Ai P, Zheng D, Jiang Y, Liu X, Pan S . Cerebrospinal fluid pentraxin 3 and CD40 ligand in anti-N-menthyl-d-aspartate receptor encephalitis. J Neuroimmunol. 2018; 315:40-44. DOI: 10.1016/j.jneuroim.2017.11.016. View

Dalmau J, Gleichman A, Hughes E, Rossi J, Peng X, Lai M . Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008; 7(12):1091-8. PMC: 2607118. DOI: 10.1016/S1474-4422(08)70224-2. View

McDougall S, Munzberg H, Derbenev A, Zsombok A . Central control of autonomic functions in health and disease. Front Neurosci. 2015; 8:440. PMC: 4288135. DOI: 10.3389/fnins.2014.00440. View

Titulaer M, McCracken L, Gabilondo I, Armangue T, Glaser C, Iizuka T . Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013; 12(2):157-65. PMC: 3563251. DOI: 10.1016/S1474-4422(12)70310-1. View

de Montmollin E, Demeret S, Brule N, Conrad M, Dailler F, Lerolle N . Anti-N-Methyl-d-Aspartate Receptor Encephalitis in Adult Patients Requiring Intensive Care. Am J Respir Crit Care Med. 2016; 195(4):491-499. DOI: 10.1164/rccm.201603-0507OC. View

Yan L, Zhang S, Huang X, Tang Y, Wu J . Clinical Study of Autonomic Dysfunction in Patients With Anti-NMDA Receptor Encephalitis. Front Neurol. 2021; 12:609750. PMC: 7894204. DOI: 10.3389/fneur.2021.609750. View

Kim C, Lee S, Kim S, Park C, Wang K, Cho B . Antitumor activity of CKD-602, a camptothecin derivative, in a mouse glioma model. J Clin Neurosci. 2011; 19(2):301-5. DOI: 10.1016/j.jocn.2011.03.032. View

Zhang Y, Liu G, Jiang M, Chen W, He Y, Su Y . Clinical Characteristics and Prognosis of Severe Anti-N-methyl-D-aspartate Receptor Encephalitis Patients. Neurocrit Care. 2018; 29(2):264-272. DOI: 10.1007/s12028-018-0536-6. View

10.

Byun J, Lee S, Moon J, Jung K, Shin J, Sunwoo J . Cardiac sympathetic dysfunction in anti-NMDA receptor encephalitis. Auton Neurosci. 2015; 193:142-6. DOI: 10.1016/j.autneu.2015.08.002. View

11.

Wang Y, Zhang W, Yin J, Lu Q, Yin F, He F . Anti-N-methyl-d-aspartate receptor encephalitis in children of Central South China: Clinical features, treatment, influencing factors, and outcomes. J Neuroimmunol. 2017; 312:59-65. DOI: 10.1016/j.jneuroim.2017.09.005. View

12.

Dampney R . Central neural control of the cardiovascular system: current perspectives. Adv Physiol Educ. 2016; 40(3):283-96. DOI: 10.1152/advan.00027.2016. View

13.

Gibbons C . Basics of autonomic nervous system function. Handb Clin Neurol. 2019; 160:407-418. DOI: 10.1016/B978-0-444-64032-1.00027-8. View

13.

Wang Z, Zhu B, Fu L, Yan J . Etiology and Clinical Features of Diplopia in South China: Analysis of 303 Cases. Front Neurol. 2022; 12:805253. PMC: 8889929. DOI: 10.3389/fneur.2021.805253. View

14.

Florance N, Davis R, Lam C, Szperka C, Zhou L, Ahmad S . Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol. 2009; 66(1):11-8. PMC: 2826225. DOI: 10.1002/ana.21756. View

15.

Sposato L, J Hilz M, Aspberg S, Murthy S, Bahit M, Hsieh C . Post-Stroke Cardiovascular Complications and Neurogenic Cardiac Injury: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020; 76(23):2768-2785. DOI: 10.1016/j.jacc.2020.10.009. View

16.

Dou X, Li D, Wu F, Wang Z, Niu M, Wu Y . The clinical features, treatment and outcomes of 33 children from Northwestern China with Anti-N-methyl-D-aspartate receptor encephalitis. Neurol Res. 2021; 44(5):429-438. DOI: 10.1080/01616412.2021.2000824. View

17.

Ren H, Fan S, Zhao Y, Guan H . The changing spectrum of antibody-mediated encephalitis in China. J Neuroimmunol. 2021; 361:577753. DOI: 10.1016/j.jneuroim.2021.577753. View